Clinical trialNCT01778634CompletedPhase 2Interventional

Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants

SponsorUniversity of Maryland, BaltimoreEnrollment121Ureaplasma Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to determine whether intravenous azithromycin is effective in eradicating Ureaplasma respiratory tract infection in preterm infants born at 24 to 28 weeks gestation.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

David A Kaufman, M.D.
University of Virginia
Principal Investigator
clinicaltrials.gov ↗
Michael L Terrin, M.D.
University of Maryland, College Park
Principal Investigator
clinicaltrials.gov ↗
Namasivayam Ambalavanan, M.D.
University of Alabama at Birmingham
Principal Investigator
clinicaltrials.gov ↗
Pamela Donohue, ScD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗
Rose M Viscardi, M.D.
University of Maryland, College Park
Study Chair
clinicaltrials.gov ↗
Susan J Dulkerian, M.D.
Mercy Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

University of Alabama at Birmingham
Birmingham, Alabama, United States
Christiana Care Health Services
Newark, Delaware, United States
Johns Hopkins University
Baltimore, Maryland, United States
Mercy Medical Center
Baltimore, Maryland, United States
University of Maryland School of Medicine
Baltimore, Maryland, United States
Monroe Carell Jr. Children'S Hospital at Vanderbilt
Nashville, Tennessee, United States
University of Virginia
Charlottesville, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Azithromycin →Placebo

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Jul 2013
Primary completion: 31 Dec 2016
Completion: 3 Nov 2020
Last update posted: 30 Nov 2020
Registered enrollment: 121
Registry id: NCT01778634

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.